Articles and posts This page contains articles and posts from 2018 to 2024. USelectAllNewsPresentationsArticlesThe Q2 report presentation of 2024!August 15, 2024 | News, PresentationsClinical potential in neonatal respiratory monitoring with Neola®’s GASMAS technologyAugust 6, 2024 | ArticlesChefakademin invites CEO Hanna Sjöström in an exclusive interviewJuly 2, 2024 | Articles, NewsLund University Master Thesis on expanding Neola Medical’s technology to more patient groupsJune 19, 2024 | Articles, NewsNeola® obtains CB certification and meets partial regulatory requirements for market approval in the USAJune 4, 2024 | News, Non regulatoryNew CFO at Neola Medical ahead of market launch in the U.S.May 31, 2024 | News, RegulatoryStrong attendance at successful Annual General Meeting 2024May 24, 2024 | Articles, NewsNeola Medical Publishes Communiqué from the Annual General Meeting 2024May 22, 2024 | Articles, News, RegulatoryBioStock – Successful Human Factors Validation Study by Neola MedicalMay 22, 2024 | Articles, NewsNeola Medical Q1 Report 2024 – Successful Study in the USA Ahead of Regulatory Approval for Neola®May 22, 2024 | News, RegulatorySwedenBio raises the importance of board competence within the Life Science industry at Annual Meeting in StockholmMay 17, 2024 | Articles, NewsCardeon’s entire shareholding in Neola Medical acquired by major shareholdersMay 14, 2024 | News, Non regulatory# 1234567891011121314151617181920212223242526272829 $ Subscribe For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Clinical potential in neonatal respiratory monitoring with Neola®’s GASMAS technologyAugust 6, 2024 | Articles
Lund University Master Thesis on expanding Neola Medical’s technology to more patient groupsJune 19, 2024 | Articles, News
Neola® obtains CB certification and meets partial regulatory requirements for market approval in the USAJune 4, 2024 | News, Non regulatory
Neola Medical Publishes Communiqué from the Annual General Meeting 2024May 22, 2024 | Articles, News, Regulatory
Neola Medical Q1 Report 2024 – Successful Study in the USA Ahead of Regulatory Approval for Neola®May 22, 2024 | News, Regulatory
SwedenBio raises the importance of board competence within the Life Science industry at Annual Meeting in StockholmMay 17, 2024 | Articles, News
Cardeon’s entire shareholding in Neola Medical acquired by major shareholdersMay 14, 2024 | News, Non regulatory